RANBP9 as potential therapeutic target in non-small cell lung cancer

Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related deaths in the Western world. Despite progress made with targeted therapies and immune checkpoint inhibitors, the vast majority of patients have to undergo chemotherapy with platinum-based drugs. To increase efficacy and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Tessari, Anna, Soliman, Shimaa H. A., Orlacchio, Arturo, Capece, Marina, Amann, Joseph M., Visone, Rosa, Carbone, David P., Palmieri, Dario, Coppola, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589326/
https://www.ncbi.nlm.nih.gov/pubmed/34778565
http://dx.doi.org/10.20517/2394-4722.2020.32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589326/
https://www.ncbi.nlm.nih.gov/pubmed/34778565
http://dx.doi.org/10.20517/2394-4722.2020.32

Ejemplares similares